Metraipolis › archive › dc_079b0c7ecf40

Predicting survival of patients treated with antibody-drug conjugates in early-phase clinical trials using AI-quantified 3D body composition on CT scans — Europe PMC PMID:42211497

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42211497
DOI
10.3389/fonc.2026.1687383
License (as archived)
solo-consultazione
Archived
2026-11-02T10:52:27.398Z
SHA-256 of the archived text
96f0c710ce1244228fcb60db61a6a1dd7a983a56a549ebcbe3b8b2ab4ecba74d
Stable URL of this page
https://metraipolis.com/documento/dc_079b0c7ecf40

How to cite

Predicting survival of patients treated with antibody-drug conjugates in early-phase clinical trials using AI-quantified 3D body composition on CT scans — Europe PMC PMID:42211497 — Europe PMC (en), https://europepmc.org/article/MED/42211497 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_079b0c7ecf40 (Metraipolis archive dc_079b0c7ecf40, sha256 96f0c710ce1244228fcb60db61a6a1dd7a983a56a549ebcbe3b8b2ab4ecba74d)
BibTeX
@misc{dc079b0c7ecf40,
  title = {Predicting survival of patients treated with antibody-drug conjugates in early-phase clinical trials using AI-quantified 3D body composition on CT scans — Europe PMC PMID:42211497},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42211497},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_079b0c7ecf40; sha256 96f0c710ce1244228fcb60db61a6a1dd7a983a56a549ebcbe3b8b2ab4ecba74d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42211497. Agents can read the archived copy with the MCP tool read_document.